Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial
Author
Jaén-Moreno, M. J.
Feu, Nuria
Redondo-Écija, Justa
Montiel, Francisco Javier
Jiménez Gómez, Cristina
Del Pozo, Gloria I.
Alcalá, José Ángel
Gutiérrez-Rojas, Luis
Balanzá-Martínez, Vicent
Chauca, Geli Marie
Carrión, Laura
Osuna, María Isabel
Sánchez, María Dolores
Caro, Inmaculada
Ayora, Miriam
Valdivia, Francisca
López, María Soledad
Poyato, José Manuel
Sarramea, Fernando
Publisher
BMC (Springer)Date
2019Subject
Bipolar disorderChronic obstructive pulmonary disease
Mobile technology
Schizophrenia
Screening
Tobacco cessation
METS:
Mostrar el registro METSPREMIS:
Mostrar el registro PREMISMetadata
Show full item recordAbstract
Background: There is an increased risk of premature death in people with severe mental illness (SMI). Respiratory disorders and cardiovascular disease are leading causes of increased mortality rates in these patients, and tobacco consumption remains the most preventable risk factor involved. Developing new tools to motivate patients towards cessation of smoking is a high priority. Information on the motivational value of giving the lung age and prevention opportunities is unknown in this high-risk population.
Methods/design: This article describes in detail a protocol developed to evaluate an intensive motivational tool, based on the individual risks of pulmonary damage and prevention opportunities. It is designed as a randomized, 12-month, follow-up, multicenter study. A minimum of 204 smokers will be included, aged 40 years and older, all of whom are patients diagnosed with either schizophrenia or bipolar disorder (BD). Chronic obstructive pulmonary disease (COPD) will be evaluated using spirometry, and the diagnosis will then be validated by a pneumologist and the lung age estimated. Based on this value, a motivational message about prevention will be issued for the intervention group, which will be reinforced by individualized text messages over a period of 3 months. The efficacy of the method and the pulmonary damage variables will be evaluated: smoking cessation at the end of follow-up will be confirmed by cooximetry, and the COPD diagnosis and the severity of the staging for disease will be assessed.
Discussion: In the context of community care, screening and early detection of lung damage could potentially be used, together with mobile technology, in order to produce a prevention message, which may provide patients with SMI with a better chance of quitting smoking.